PPCB Stock Analysis: Buy, Sell, or Hold?
PPCB - Propanc Biopharma, Inc. Common Stock
$0.23
-0.05 (-18.03%)
▼
5d:
-18.64%
30d:
-60.72%
90d:
-82.61%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026
10d
Get Alerted When PPCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called PPCB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PPCB is down 18.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PPCB is down 18.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PPCB is currently trading at $0.23, which is considered oversold relative to its 30-day fair value range of $0.30 to $0.58.
Technical Outlook: Technically, PPCB is in a strong downtrend. Immediate support is located at $0.20, while resistance sits at $0.40. Short-term momentum is weak, with the stock down 18.0% recently.
Market Sentiment: PPCB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.52 (+567.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PPCB is in a strong downtrend. Immediate support is located at $0.20, while resistance sits at $0.40. Short-term momentum is weak, with the stock down 18.0% recently.
Market Sentiment: PPCB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $1.52 (+567.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.30 -
$0.58
Company Quality Score
39/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
84.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-18.0%)
- BULLISH: Trading 567.3% below Wall St target ($1.52)
- WARNING: Recommendation downgraded due to -18.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.30 -
$0.58
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.20
Resistance Level
$0.40
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$1.52
(+567.3%)
Last updated: February 02, 2026 5:07 AM ET
Data refreshes hourly during market hours. Next update: 6:07 AM
Data refreshes hourly during market hours. Next update: 6:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPCB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |